Shopping Cart 0
Cart Subtotal
AED 0

Interface Biologics Inc - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic additives and combination drug delivery devices. IBI provides Endexo technology for blood contacting medical devices that address thrombosis problems; Epidel anti-infective polymers that allow for pharmaceuticals to be integrated directly into medical devices; and Kinesyx bioactive surface pacifying oligomers. It serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Interface Biologics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Interface Biologics Inc Company Overview

Interface Biologics Inc Company Snapshot

Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview

Interface Biologics Inc-Pipeline Analysis Overview

Interface Biologics Inc-Key Facts

Interface Biologics Inc-Major Products and Services

Interface Biologics Inc Pipeline Products by Development Stage

Interface Biologics Inc Pipeline Products Overview

EPICUFF

EPICUFF Product Overview

EPISCREW-Dental Implant

EPISCREW-Dental Implant Product Overview

EPISCREW-Orthopedic Fixation Device

EPISCREW-Orthopedic Fixation Device Product Overview

IBE-814 IVT

IBE-814 IVT Product Overview

Interface Biologics Inc-Key Competitors

Interface Biologics Inc-Key Employees

Interface Biologics Inc-Locations And Subsidiaries

Head Office

Recent Developments

Interface Biologics Inc, Recent Developments

May 02, 2019: Interface Biologics Poster Presentation at AUA 2019, Chicago, IL

Apr 24, 2019: Interface Biologics to present local drug delivery technology update at Bloom Burton & Co. Healthcare Investor Conference

Apr 24, 2019: Interface Biologics to present at ARVO 2019

Feb 05, 2019: Interface Biologics to focus future growth in biotech with local drug delivery platform

Dec 04, 2018: Interface Biologics announces new V.P., business development

Nov 27, 2018: Interface Biologics completes pre-IND meeting with U.S. FDA on Epidel technology for treatment of posterior Inflammatory Eye Diseases

Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors

Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification

Dec 09, 2008: Interface Appoints President And Board Member

Aug 25, 2007: Interface Appoints New Advisory Board Member

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Interface Biologics Inc Pipeline Products by Equipment Type

Interface Biologics Inc Pipeline Products by Development Stage


List Of Table

List of Tables

Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview

Interface Biologics Inc Pipeline Products by Equipment Type

Interface Biologics Inc Pipeline Products by Indication

Interface Biologics Inc, Key Facts

Interface Biologics Inc, Major Products and Services

Interface Biologics Inc Number of Pipeline Products by Development Stage

Interface Biologics Inc Pipeline Products Summary by Development Stage

EPICUFF-Product Status

EPICUFF-Product Description

EPISCREW-Dental Implant-Product Status

EPISCREW-Dental Implant-Product Description

EPISCREW-Orthopedic Fixation Device-Product Status

EPISCREW-Orthopedic Fixation Device-Product Description

IBE-814 IVT-Product Status

IBE-814 IVT-Product Description

Interface Biologics Inc, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Interface Biologics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sirius Wilderness Medicine Inc

MIV Therapeutics Inc

ARC Pharmaceuticals Inc.

Summary

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic additives and combination drug delivery devices. IBI provides Endexo technology for blood contacting medical devices that address thrombosis problems; Epidel anti-infective polymers that allow for pharmaceuticals to be integrated directly into medical devices; and Kinesyx bioactive surface pacifying oligomers. It serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Interface Biologics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Interface Biologics Inc Company Overview

Interface Biologics Inc Company Snapshot

Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview

Interface Biologics Inc-Pipeline Analysis Overview

Interface Biologics Inc-Key Facts

Interface Biologics Inc-Major Products and Services

Interface Biologics Inc Pipeline Products by Development Stage

Interface Biologics Inc Pipeline Products Overview

EPICUFF

EPICUFF Product Overview

EPISCREW-Dental Implant

EPISCREW-Dental Implant Product Overview

EPISCREW-Orthopedic Fixation Device

EPISCREW-Orthopedic Fixation Device Product Overview

IBE-814 IVT

IBE-814 IVT Product Overview

Interface Biologics Inc-Key Competitors

Interface Biologics Inc-Key Employees

Interface Biologics Inc-Locations And Subsidiaries

Head Office

Recent Developments

Interface Biologics Inc, Recent Developments

May 02, 2019: Interface Biologics Poster Presentation at AUA 2019, Chicago, IL

Apr 24, 2019: Interface Biologics to present local drug delivery technology update at Bloom Burton & Co. Healthcare Investor Conference

Apr 24, 2019: Interface Biologics to present at ARVO 2019

Feb 05, 2019: Interface Biologics to focus future growth in biotech with local drug delivery platform

Dec 04, 2018: Interface Biologics announces new V.P., business development

Nov 27, 2018: Interface Biologics completes pre-IND meeting with U.S. FDA on Epidel technology for treatment of posterior Inflammatory Eye Diseases

Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors

Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification

Dec 09, 2008: Interface Appoints President And Board Member

Aug 25, 2007: Interface Appoints New Advisory Board Member

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Interface Biologics Inc Pipeline Products by Equipment Type

Interface Biologics Inc Pipeline Products by Development Stage


List Of Table

List of Tables

Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview

Interface Biologics Inc Pipeline Products by Equipment Type

Interface Biologics Inc Pipeline Products by Indication

Interface Biologics Inc, Key Facts

Interface Biologics Inc, Major Products and Services

Interface Biologics Inc Number of Pipeline Products by Development Stage

Interface Biologics Inc Pipeline Products Summary by Development Stage

EPICUFF-Product Status

EPICUFF-Product Description

EPISCREW-Dental Implant-Product Status

EPISCREW-Dental Implant-Product Description

EPISCREW-Orthopedic Fixation Device-Product Status

EPISCREW-Orthopedic Fixation Device-Product Description

IBE-814 IVT-Product Status

IBE-814 IVT-Product Description

Interface Biologics Inc, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Interface Biologics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sirius Wilderness Medicine Inc

MIV Therapeutics Inc

ARC Pharmaceuticals Inc.